Cargando…
Eye-Drops for Activation of DREADDs
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are an important tool for modulating and understanding neural circuits. Depending on the DREADD system used, DREADD-targeted neurons can be activated or repressed in vivo following a dose of the DREADD agonist clozapine-N-oxide (CN...
Autores principales: | Keenan, William T., Fernandez, Diego C., Shumway, Lukas J., Zhao, Haiqing, Hattar, Samer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703865/ https://www.ncbi.nlm.nih.gov/pubmed/29218003 http://dx.doi.org/10.3389/fncir.2017.00093 |
Ejemplares similares
-
Using DREADDs to Isolate Internal Clocks
por: Farrell, Martilias S.
Publicado: (2011) -
Satellite glia modulate sympathetic neuron survival, activity, and autonomic function
por: Mapps, Aurelia A, et al.
Publicado: (2022) -
DREADDs in Epilepsy Research: Network-Based Review
por: Mueller, John-Sebastian, et al.
Publicado: (2022) -
Comparative assessment of the effects of DREADDs and endogenously expressed GPCRs in hippocampal astrocytes on synaptic activity and memory
por: Lee, Sophie H., et al.
Publicado: (2023) -
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based
DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018)